References

  1. World Health Organization. The World Health Report 2003: Shaping the Future. 2003. Geneva, Switzerland. WHO. Google Scholar

  2. World Health Organization. Preventing Chronic Diseases: A Vital Investment. 2005. Geneva, Switzerland. WHO Press. Google Scholar

  3. Muna WF. Cardiovascular disorders in Africa. World Health Stat Q. 1993; 46(2):12-133. PubMed | Google Scholar

  4. Akinboboye O, Idris O, Akinboboye O, Akinkugbe O. Trends in coronary artery disease and associated risk factors in sub-Saharan Africans. J Hum Hypertens. 2003; 17(6): 381-387. PubMed | Google Scholar

  5. Williams R, Van Gaal, Lucioni C. Assessing the impact of the costs of type 2 diabetes. Diabetologia. 2002; 45(7):13-17. PubMed | Google Scholar

  6. Massi-Benedetti M. CODE 2 Advisory Board. The costs of diabetes type 2 in Europe; the CODE-2 study. Diabetologia. 2002; 45(7): 1- 4. PubMed | Google Scholar

  7. Jeganathan VS, Wang JJ, Wong TY. Ocular associations of diabetes other than diabetic retinopathy. Diabetes Care. 2008; 31(9): 1905-1912. PubMed | Google Scholar

  8. Seedat YK. Impact of poverty on hypertension and cardiovascular disease in sub-Saharan Africa. Cardiovasc J Afr. 2007; 18(5): 316-320. PubMed | Google Scholar

  9. Moukouri ED, Moli TM, Nouedoui C. Les aspects épidémiologiques de la rétinopathie diabétique à Yaoundé. Med Afr Noire. 1995; 42: 424-428. PubMed | Google Scholar

  10. Sobngwi E, Mbanya JC, Moukouri EN, Ngu KB. Microalbuminuria and retinopathy in a diabetic population in Cameroon. Diabetes Res Clin Pract. 1999; 44(3): 186-191. PubMed | Google Scholar

  11. Diallo J. La rétinopathie diabétique à Dakar. Med Afr Noire. 1972; 19(12): 885-890. PubMed | Google Scholar

  12. Lester FT. Diabetes mellitus. Clinical features in 404 Europians. Ethiopia Med J. 1976; 14(4) : 185-198. PubMed | Google Scholar

  13. Wade A. La rétinopathie diabétique chez les Noirs Africains. Med Afr Noire. 1979; 26(12) : 913-916. PubMed | Google Scholar

  14. Koki G, Assumpta LB, Eballe AO, Epee E, Sobngwi E et al. Rétinopathie diabétique du Noir africain : étude angiographique. Santé .2010; 20(3) : 127-132. PubMed | Google Scholar

  15. El Mahdi EM, Abdel Rahman I, Mukhtar S. Pattern of diabetes mellitus in the Sudan. Trop Geogr Med. 1989; 41(4): 353-357. PubMed | Google Scholar

  16. Nambuya AP, Otim MA, Whitehead H, Mulvany D, Kennedy R, Hadden DR. The presentation of newly-diagnosed diabetic patients in Uganda. QJM. 1996; 89(9): 705-711. PubMed | Google Scholar

  17. Elbagir MN, Eltom MA, Mahadi EO, Berne C. Pattern of long-term complications in Sudanese insulin-treated diabetic patients. Diabetes Res Clin Pract. 1995; 30(1): 59-67. PubMed | Google Scholar

  18. Djrolo F, Doutetien C, Attolou V. La microangiopathie diabétique : Etude de la concordance entre la rétinopathie et la néphropathie dans une population de diabétiques noirs africains à Cotonou (Bénin). Santé. 2001; 11(2): 105-109. PubMed | Google Scholar

  19. Crini S, Cipolli D, Infantone E, Infantone L, Lunetta M. Microalbuminuria and severity of diabetic retinopathy in type 1 diabetic patients: Association and relationship with some risk factors. Diabete & Metabolism. 1995; 21(6): 440-445. PubMed | Google Scholar

  20. Pedersen ML, Jacobsen JL, Lynge AR. Micro and macrovascular complications among Greenlanders and Danes with type 2 diabetes mellitus in Nuuk, Greenland. Int J Circumpolar Health. 2009; 69(2): 195-207. PubMed | Google Scholar

  21. Rolfe M. Diabetic eye disease in Central Africa. Diabetologia. 1988; 31(2): 88-92. PubMed | Google Scholar

  22. Elmahdi EM, Kaballo AM, Mukhtar EA. Features of non insulin-dependent diabetes mellitus (NIDDM) in the Sudan. Diabetes Res Clin Pract. 1991; 11(1): 59-63. PubMed | Google Scholar

  23. Niang EH, Diop SN, Sidibe EA, Badiane M, Lamouche JP, Sow AM. Echographic and velocimetric aspects of arteriopathies in the diabetic. Dakar Med. 1994; 39(1): 37-42. PubMed | Google Scholar

  24. Sano D, Tieno H, Drabo Y, Sanou A. Prise en charge du pied diabétique à propos de 42 cas au CHU de Ouagadougou. Med Afr Noire. 1999; 46(6): 307-311. PubMed | Google Scholar

  25. Mills JL Beckett WC, Spence M, Taylor M. The diabetic foot consequences of delay treatment and referral. South Med J. 1991; 84(8): 970-974. PubMed | Google Scholar

  26. Hunt JA. Foot infections in diabetes are rarely due to a single micro-organism. Diabetic Med. 1992; 9(8): 749-752. PubMed | Google Scholar

  27. Larsson J, Apelqvist J, Castenfors J, Agardh CD, Stenstrom A. A distal blood pressure as a predictor for the level of amputation in diabetic patients with foot ulcer. Foot Ankle. 1993; 14(5): 247-253. PubMed | Google Scholar

  28. Apelqvist J, Bakker K, van Houtum WH, Nabuurs-Franssen MH, Schaper NC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2000; 16(Suppl 1): 84-92. PubMed | Google Scholar

  29. Pedersen ML, Jacobsen JL, Lynge AR. Micro and macrovascular complications among Greenlanders and Danes with type 2 diabetes mellitus in Nuuk, Greenland. Int J Circumpolar Health. 2009; 69(2): 195-207. PubMed | Google Scholar

  30. Feldt-Rasmussen B. Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab. 2000; 26(suppl 4): 64-66. PubMed | Google Scholar

  31. Halimi JM, Hadjadj S, Aboyans V, Allaert FA, Artigou JY, Beaufils M, Berrut G, Fauvel JP, Gin H, Nitenberg A, Renversez JC, Rusch E, Valensi P, Cordonnier D. Microalbuminurie et excrétion urinaire d'albumine: recommandations pour la pratique clinique. Nephrol Ther. 2007; 3(6): 384-391. PubMed | Google Scholar

  32. American Diabetes Association. Physical activity/exercise and diabetes. Diabetes Care. 2004. USA. American Diabetes Association. PubMed | Google Scholar

  33. Tanasescu M, Leitzmann MF, Rimm EB, Hu FB. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation. 2003; 107(19): 2435-2439. PubMed | Google Scholar

  34. Perkovic V, Verdon C, Ninomiya T, Barzi1 F, Cass A et al. The Relationship between Proteinuria and Coronary Risk: A Systematic Review and Meta-Analysis. PLoS Med. 2008; 5(10): 1486-1495. PubMed | Google Scholar

  35. Gilbert RE, Tsalamandris C, Allen TJ, Colville D, Jerum G. Early nephropathy predicts vision threatening retinal disease in patients with type 1 diabetes mellitus. J Am Soc Nephrol. 1998; 9(1): 85-89. PubMed | Google Scholar

  36. Campos-Pastor MM, Escobar-Jiménez F, Mezquita P, Herrera-Pombo JL, et al. Factors associated with microalbuminuria in type 1 diabetes mellitus : a cross sectional study. Diabetes Res Clin Pract. 2000; 48(1): 43-49. PubMed | Google Scholar

  37. Voutilainen RM, Teräsvirta ME, Uusitupa MI, Niskanen LK. Occurrence and predictors of retinopathy and visual acuity in type 2 diabetic patients and control subjects. 10-year follow up from the diagnosis. J Diabetes Complications. 2001; 15(1): 24-33. PubMed | Google Scholar

  38. Marre M. Microalbuminurie : signification et intérêt. Presse Med. 1993; 22(23): 1098-1103. PubMed | Google Scholar

  39. Marre M, Girault A, Vasmont D. Prevalence of microalbuminuria in french type 2 diabetics followed by their general practitionner. Diabetes & Metabolism. 1995; 21(1): 34-40. PubMed | Google Scholar

  40. Romero P, Espeso O, Del Castillo D. Estudio prospectivo de correlacion entre retinopatia diabética y microalbuminuria en pacientes diabeticos tipo I. Arch Soc Esp Oftalmol. 2000; 75(5): 307-314. PubMed | Google Scholar

  41. Kingue S, Binam F, Pouth SF, Ouankou MD, Muna WF. Coronary artery disease in Cameroon: epidemiological and clinical aspects (30 cases). Ann Oncol. 2000; 26(101):7-11. PubMed | Google Scholar

  42. Kamotho C, Ogola EO, Joshi M, Gikonyo D. Cardiovascular risk factor profile of black Africans undergoing coronary angiography. East Afr Med J. 2004; 81(2): 82-86. PubMed | Google Scholar

  43. Thornalley PJ, McLellan AC, Lo TW, Benn J, Sönksen PH. Negative association between erythrocyte reduced glutathione concentration and diabetic complications. Clin Sci. 1996; 91(5):575-582. PubMed | Google Scholar

  44. Chous P. Diabète et yeux : ce que les personnes atteintes de diabète et les professionnels de la santé doivent savoir. Diabetes Voice. 2009; 54(3): 30-33. PubMed | Google Scholar

  45. Bloomgarden ZT. Screening for and managing diabetic retinopathy: current approaches. Am J Health Syst Pharm. 2007; 64(17 suppl 12): 8-14. PubMed | Google Scholar

  46. Epacka Ewane M, Mandengue SH, Ahmadou G, Moumbe Tamba S, Dzudie A, Luma HN. Dépistage des maladies cardiovasculaires et des facteurs de risque dans une cohorte de 270 Camerounais: Effets des activités physiques et sportives. MmM 2011; 5(6): 655-8. Google Scholar

  47. Awah PK, Kengne AP, Fezeu LK, Mbanya JC. Perceived risk factors of cardiovascular diseases and diabetes in Cameroon. Health Educ Res. 2007; 23(4): 612-620. PubMed | Google Scholar